New Market Research Report: Poland Pharmaceuticals & Healthcare Report Q3 2013
The Polish pharmaceutical market contracted severely in 2012 due to harsh pricing measures and strict margins imposed on wholesalers, pharmaceutical manufacturers and retailers. Moreover, over the course of the year, the burden of pharmaceutical spending shifted onto the Polish consumer, as the harsher reimbursement regime caused a rise in private contributions to prescription payments. We forecast a return to growth in 2013, driven by demand for hospitals and private consumption growth as the Polish government entrenches cuts to drug expenditure....
View full press release